Bekou Eleni, Mulita Admir, Seimenis Ioannis, Kotini Athanasia, Courcoutsakis Nikolaos, Koukourakis Michael I, Mulita Francesk, Karavasilis Efstratios
Medical Physics Laboratory, School of Medicine, Democritus University of Thrace, 69100 Alexandroupolis, Greece.
Department of Radiotherapy/Oncology, School of Medicine, Democritus University of Thrace, 69100 Alexandroupolis, Greece.
Clin Pract. 2024 Dec 27;15(1):4. doi: 10.3390/clinpract15010004.
: This study aimed to investigate the prognostic value of advanced techniques of magnetic resonance imaging (MRI) biochemical recurrence (BCR) after radiotherapy in patients with prostate cancer (PCa). : A comprehensive literature review was conducted to evaluate the role of MRI in detecting BCR of PCa patients after external beam radiation therapy. : National guidelines do not recommend imaging techniques in clinical follow-up PCa. However, in 2021, the European Association of Urogenital Radiology (ESUR), the European Association of Urological Imaging (ESUI), and the PI-RADS Steering Committee introduced the Prostate Imaging for Recurrence Reporting (PI-RR) system. PI-RR incorporates the MRI biomarkers in the post-treatment process. In the last decade, a growing number of clinical researchers have investigated the role of various MRI techniques in BCR. : The integration of advanced MRI technologies into clinical routine marks the beginning of a new era of BCR with accuracy.
本研究旨在探讨先进的磁共振成像(MRI)技术对前列腺癌(PCa)患者放疗后生化复发(BCR)的预后价值。进行全面的文献综述以评估MRI在检测接受外照射放疗的PCa患者BCR中的作用。国家指南不建议在PCa临床随访中使用成像技术。然而,2021年,欧洲泌尿生殖放射学会(ESUR)、欧洲泌尿外科影像学会(ESUI)和PI-RADS指导委员会推出了前列腺复发成像报告(PI-RR)系统。PI-RR将MRI生物标志物纳入治疗后过程。在过去十年中,越来越多的临床研究人员研究了各种MRI技术在BCR中的作用。将先进的MRI技术整合到临床常规中标志着BCR精准新时代的开始。